NCT01446445View on ClinicalTrials.gov

Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Infection in Solid Organ Transplant Recipients

Interventions

DRUG

Ganciclovir/ Valganciclovir according to SPC

Doses according to Summaries of Product Characteristics (SPC)

DRUG

Ganciclovir/ Valganciclovir according to PK model

Doses according to population pharmacokinetic model

Trial Locations (1)

08028

Nephrology Department- Hospital Universitari Bellvtge, L'Hospitalet de Llobregat

All Listed Sponsors

collaborator

Ministerio de Sanidad, Servicios Sociales e Igualdad

OTHER_GOV

lead

Nuria Lloberas

OTHER

NCT01446445 - Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients. | Biotech Hunter | Biotech Hunter